JPS59501961A - 赤血球濾過装置 - Google Patents
赤血球濾過装置Info
- Publication number
- JPS59501961A JPS59501961A JP58503487A JP50348783A JPS59501961A JP S59501961 A JPS59501961 A JP S59501961A JP 58503487 A JP58503487 A JP 58503487A JP 50348783 A JP50348783 A JP 50348783A JP S59501961 A JPS59501961 A JP S59501961A
- Authority
- JP
- Japan
- Prior art keywords
- blood
- red blood
- membrane
- strip
- microns
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000003743 erythrocyte Anatomy 0.000 title claims description 53
- 238000001914 filtration Methods 0.000 title description 29
- 210000004369 blood Anatomy 0.000 claims description 50
- 239000008280 blood Substances 0.000 claims description 50
- 239000012528 membrane Substances 0.000 claims description 39
- 239000011148 porous material Substances 0.000 claims description 31
- 230000002745 absorbent Effects 0.000 claims description 25
- 239000002250 absorbent Substances 0.000 claims description 25
- 238000010521 absorption reaction Methods 0.000 claims description 23
- 238000000034 method Methods 0.000 claims description 18
- 230000005484 gravity Effects 0.000 claims description 4
- 230000009471 action Effects 0.000 claims description 2
- 239000000853 adhesive Substances 0.000 claims description 2
- 230000001070 adhesive effect Effects 0.000 claims description 2
- 210000000601 blood cell Anatomy 0.000 claims description 2
- 206010011224 Cough Diseases 0.000 claims 1
- 230000017531 blood circulation Effects 0.000 claims 1
- 239000012530 fluid Substances 0.000 description 24
- 238000005259 measurement Methods 0.000 description 7
- 208000007056 sickle cell anemia Diseases 0.000 description 7
- 230000002159 abnormal effect Effects 0.000 description 6
- 230000008859 change Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 238000005534 hematocrit Methods 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 238000011085 pressure filtration Methods 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000010408 film Substances 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000012266 salt solution Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 208000008601 Polycythemia Diseases 0.000 description 1
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 1
- 241001648319 Toronia toru Species 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 208000009601 hereditary spherocytosis Diseases 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- HIEHAIZHJZLEPQ-UHFFFAOYSA-M sodium;naphthalene-1-sulfonate Chemical compound [Na+].C1=CC=C2C(S(=O)(=O)[O-])=CC=CC2=C1 HIEHAIZHJZLEPQ-UHFFFAOYSA-M 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US432635DEEDK | 1982-10-04 | ||
| PCT/US1983/001544 WO1984001429A1 (en) | 1982-10-04 | 1983-10-04 | Process and device for erythrocyte deformation determination |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS59501961A true JPS59501961A (ja) | 1984-11-22 |
| JPH0252220B2 JPH0252220B2 (enrdf_load_stackoverflow) | 1990-11-09 |
Family
ID=22175473
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58503487A Granted JPS59501961A (ja) | 1982-10-04 | 1983-10-04 | 赤血球濾過装置 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS59501961A (enrdf_load_stackoverflow) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01501170A (ja) * | 1986-10-17 | 1989-04-20 | バクスター、インターナショナル、インコーポレイテッド | 血液成分処理システムにおいてヘマトクリットを見積るための方法および装置 |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5481069A (en) * | 1994-01-03 | 1996-01-02 | International Business Machines Corporation | Ribbon cable with terminal edge reinforcement |
-
1983
- 1983-10-04 JP JP58503487A patent/JPS59501961A/ja active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01501170A (ja) * | 1986-10-17 | 1989-04-20 | バクスター、インターナショナル、インコーポレイテッド | 血液成分処理システムにおいてヘマトクリットを見積るための方法および装置 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0252220B2 (enrdf_load_stackoverflow) | 1990-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4491012A (en) | Method for measuring erythrocyte deformability | |
| Lonnroth et al. | A microdialysis method allowing characterization of intercellular water space in humans | |
| Kikuchi et al. | Improved filtration method for red cell deformability measurement | |
| Schilling | The blood picture and its clinical significance (including tropical diseases): a guidebook on the microscopy of blood | |
| Koutsouris et al. | Determination of erythrocyte transit times through micropores. I-Basic operational principles | |
| WINTROBE | The erythrocyte in man | |
| Markle et al. | Force relaxation and permanent deformation of erythrocyte membrane | |
| CN102802521B (zh) | 测量生物数据的试条和测量生物数据的方法 | |
| CN109804243A (zh) | 血浆分离装置和血浆分离方法 | |
| Barfuss et al. | Hyperosmolality of absorbate from isolated rabbit proximal tubules | |
| JPS59501961A (ja) | 赤血球濾過装置 | |
| Mangos | Transductal fluxes of Na, K, and water in the human eccrine sweat gland | |
| Reinhart | The influence of iron deficiency on erythrocyte deformability | |
| Böhler et al. | Mechanical fragility of erythrocyte membrane in neonates and adults | |
| Rous et al. | A rapid and simple method of testing donors for transfusion | |
| SWANK et al. | Blood cell aggregation and screen filtration pressure | |
| Thomson et al. | Demonstration of tube leukocyte adherence inhibition assay with coded samples of blood | |
| US4402216A (en) | Erythrocyte deformability monitor | |
| Waugh et al. | Shear rate-dependence of leukocyte cytoplasmic viscosity | |
| Athanassiou et al. | Deformability of the erythrocyte membrane in patients with myelodysplastic syndromes | |
| Ramanathan | Physiology Practical Manual, -E-Book: Physiology Practical Manual, -E-Book | |
| Egger | A noninvasive membrane filter method for in vivo determination of leukocyte migration in man | |
| Tutuarima et al. | An improved method for the concentration of cerebrospinal fluid cells by suction tip and sedimentation chamber | |
| Lauweryns et al. | The body lymphatics in neonatal hyaline membrane disease | |
| Velker | Erythrocyte Deformability as Assessed by Nuclepore Filters |